M. V. Karamouzis

Phase II study of pegylated liposomal doxorubicin (Caelyx®) and docetaxel as first-line treatment in metastatic breast cancer

A. Alexopoulos, M. V. Karamouzis, H. Stavrinides et al. · Annals of Oncology · 2004 · 48 citations · Full text

Medicine, Oncology, Pharmacology +16

Evidence for in vivo synergism between docetaxel and gemcitabine in patients with metastatic breast cancer

A. Alexopoulos, Dimitrios Tryfonopoulos, M. V. Karamouzis et al. · Annals of Oncology · 2003 · 48 citations · Full text

Medicine, Oncology, Pharmacology +12

Quality of life in metastatic breast cancer patients under chemotherapy or supportive care: a single-institution comparative study

M. V. Karamouzis, George Ioannidis, G. Rigatos · European Journal of Cancer Care · 2007 · 40 citations

Medicine, Oncology, Breast Oncology +16

Phase II trial of pemetrexed (P) and bevacizumab (B) in patients (pts) with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC): An interim analysis

M. V. Karamouzis, David Friedland, R. R. Johnson et al. · Journal of Clinical Oncology · 2007 · 20 citations

Medicine, Oncology, Pharmacology +15

Phase I trial of pemetrexed in combination with cetuximab and concurrent radiotherapy in patients with head and neck cancer

Athanassios Argiris, M. V. Karamouzis, Ryan P. Smith et al. · Annals of Oncology · 2011 · 14 citations · Full text

Medicine, Oncology, Radiation Oncology +10